Drug Information

Drug General Information
Drug ID
D0EH0C
Former ID
DIB006063
Drug Name
AV-965
Indication Alzheimer disease [ICD9: 331; ICD10:G30] Phase 1 [548413]
Company
Avera Pharmaceuticals Inc
Target and Pathway
Target(s) 5-hydroxytryptamine 1A receptor Target Info Antagonist [548414]
KEGG Pathway cAMP signaling pathway
Neuroactive ligand-receptor interaction
Serotonergic synapse
PANTHER Pathway Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
5HT1 type receptor mediated signaling pathway
Reactome Serotonin receptors
G alpha (i) signalling events
WikiPathways Serotonin HTR1 Group and FOS Pathway
SIDS Susceptibility Pathways
Monoamine GPCRs
GPCRs, Class A Rhodopsin-like
GPCR ligand binding
GPCR downstream signaling
References
Ref 548413Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025412)
Ref 548414Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025412)

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.